Daily Archives: December 10, 2018

The Graduate Management Admission Council Selects Three New Business Schools for Membership

Schools Bring Expertise and Insight in Support of GMAC Mission

RESTON, Va., Dec. 10, 2018 (GLOBE NEWSWIRE) — The Graduate Management Admission Council (GMAC), a global association of leading graduate business schools, welcomes three new members.

WillScot Announces Completion of Warrant Exchange Offer

BALTIMORE, Dec. 10, 2018 (GLOBE NEWSWIRE) — WillScot Corporation (“WillScot”) (NASDAQ: WSC), the specialty rental services market leader providing innovative modular space and portable storage solutions across North America, today announced the completion of its previously announced exchange offer (the “Exchange Offer”) relating to certain outstanding warrants (the “Warrants”).

CERESPIR INCORPORATED and the NATIONAL NEUROSCIENCE INSTITUTE SINGAPORE Announce Positive Data Showing Beneficial Effects of CERESPIR’s Clinical Stage Compound Itanapraced in a LRRK2 Model of Parkinson’s Disease

  • Itanapraced blocks LRRK2 expression and LRRK2-mediated neurotoxicity
  • Itanapraced ready to advance to Phase 2 in Parkinson’s disease patients with and without genetic mutation

NEW YORK and SINGAPORE, Dec. 10, 2018 (GLOBE NEWSWIRE) — CERESPIR INCORPORATED a pharmaceutical company engaged in the discovery and development of disease-modifying therapeutics for the treatment of neurodegenerative diseases, and THE NATIONAL NEUROSCIENCE INSTITUTE SINGAPORE, a national and international center of excellence in neuroscience with its mission to improve lives through integrated clinical service, research and education, announced today that they have obtained animal proof of concept for CERESPIR’s clinical stage compound itanapraced in Parkinson’s disease models.  

CERESPIR INCORPORATED and the NATIONAL NEUROSCIENCE INSTITUTE SINGAPORE Announce Positive Data Showing Beneficial Effects of CERESPIR’s Clinical Stage Compound Itanapraced in a LRRK2 Model of Parkinson’s Disease

  • Itanapraced blocks LRRK2 expression and LRRK2-mediated neurotoxicity
  • Itanapraced ready to advance to Phase 2 in Parkinson’s disease patients with and without genetic mutation

NEW YORK and SINGAPORE, Dec. 10, 2018 (GLOBE NEWSWIRE) — CERESPIR INCORPORATED a pharmaceutical company engaged in the discovery and development of disease-modifying therapeutics for the treatment of neurodegenerative diseases, and THE NATIONAL NEUROSCIENCE INSTITUTE SINGAPORE, a national and international center of excellence in neuroscience with its mission to improve lives through integrated clinical service, research and education, announced today that they have obtained animal proof of concept for CERESPIR’s clinical stage compound itanapraced in Parkinson’s disease models.  

DSM Sinochem Pharmaceuticals announces its new name – Centrient Pharmaceuticals

The name, resulting from a change in ownership, reflects its role at the centre of modern healthcare

ROTTERDAM, Netherlands, Dec. 10, 2018 (GLOBE NEWSWIRE) — Effective December 10, 2018 Centrient Pharmaceuticals is the new name for DSM Sinochem Pharmaceuticals, the leading manufacturer of beta-lactam antibiotics and a provider of next-generation statins and anti-fungals.

Fraser Institute News Release: China ranks 135th out of 162 in new Human Freedom Index; Canada ranks 5th

TORONTO, Dec. 10, 2018 (GLOBE NEWSWIRE) — China continues to languish near the bottom of the annual Human Freedom Index released today by the Fraser Institute and a network of international public policy think-tanks.

700 delegates attend Vietnamese Students’ Association Congress

The Party and the State value students and work to build a generation of Vietnamese young people who are patriotic and faithful to the ideal of national independence and socialism, said Prime Minister Nguyen Xuan Phuc at the 10th National Congress of the Vietnamese Students’ Association.…